Skip to main content
. 2024 May 24;10(2):e004302. doi: 10.1136/rmdopen-2024-004302

Table 2.

Performance metrics of detection of the assessed variables

TP FP FN Annotations Precision Recall F1-score
Uveitis 277 1 1 278 0.996 0.996 0.996
Dactylitis 94 3 2 96 0.969 0.979 0.974
SpA 147 5 3 150 0.967 0.980 0.974
Enthesitis 392 2 38 430 0.995 0.912 0.951
AxSpA 16 1 1 17 0.941 0.941 0.941
AS 73 20 4 77 0.785 0.948 0.859
pSpA 4 0 2 6 1.000 0.667 0.800
Infliximab 11 0 0 11 1.000 1.000 1.000
Etanercept 32 1 1 33 0.970 0.970 0.970
Adalimumab 46 3 0 46 0.939 1.000 0.968

AS, ankylosing spondylitis (currently r-axSpA); axSpA, axial SpA; FN, false negative; FP, false positive; pSpA, peripheral SpA; SpA, spondyloarthritis; TP, true positive.